Samsung nets FDA clearanceKorean PACS vendor Samsung has officially entered the U.S. market, with news that its Raypax PACS product line has received Food and Drug Administration 510(k) clearance. Raypax is based on Windows NT and Windows 98
Korean PACS vendor Samsung has officially entered the U.S. market, with news that its Raypax PACS product line has received Food and Drug Administration 510(k) clearance. Raypax is based on Windows NT and Windows 98 architecture, although its image server is also available on the Unix platform (
PNN
9/98).
Raypax comprises display software, an image server, a Web server, a film and plain paper printer server, modality interfaces, and a Web-based teleradiology system. Digitizers as well as DICOM and HL7 gateways are available. Samsung also markets a radiology information system.
Samsung, which has U.S. operations in San Jose, CA, plans to install a U.S. beta site for Raypax this month. Raypax is sold through distributors, and Asian sales of Raypax began in April. Beta testing of Raypax was performed at Samsung Medical Center in Seoul.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.